← Stack Research Tool

Pair page

HCG with Insulin

Mechanism-tag overlap and published literature for HCG and Insulin, pulled verbatim from each Kalios compound profile. Kalios is a literature reference, not a recommendation.

Mechanism overlap

Mechanism tags are verbatim labels on each compound's profile. Generic tags ("peptide", "small-molecule", "research-chemical") are excluded from this overlap view. Tags are descriptive — not an inference about combined effect.

HCG INSULIN 2 UNIQUE TAGS 1 UNIQUE TAGS 1 SHARED
HCG unique glycoprotein-gonadotropinlh-analog
Shared hormone
Insulin unique pancreatic-peptide-hormone

Quick facts

HCG

RouteSubQ / IM
Half-life~24–36 hours (biological)
FDA statusApproved (hypogonadism, cryptorchidism, infertility)
WADABanned in males (S2)
Full HCG profile →

Insulin

RouteSubQ (primary) / IV / inhaled
Half-life~4 min endogenous; hours for analogs
FDA statusApproved (1923 animal; 1982 rDNA)
WADAProhibited (S4)
Full Insulin profile →

Literature table

Classified references from each compound profile. Click a column header to sort. Click a PMID to open PubMed. Findings are quoted verbatim from each profile's literature_summary; nothing here is added or interpreted.

Year Compound Source Finding
2014HCGRastrelli G, Corona G, Mannucci E, Maggi M. Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study. Andrology. 2014;2(6):794-808. PMID: 25099686. (Meta-analysis of spermatogenesis response to gonadotropin replacement — relevant to hCG/FSH… PMID 25099686meta-analysis
2018HCGBhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID: 29562364. (Soc… PMID 29562364human study
2013HCGHsieh TC, Pastuszak AW, Hwang K, Lipshultz LI. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013;189(2):647-650. PMID: 23260550. PMID 23260550human study
2013HCGKaminetsky J, Werner M, Fontenot G, Wiehle RD. Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. J Sex Med. 2013;10(6):1628-1635. PMID: 23530575. (Adjacent SERM-based ax… PMID 23530575human study
2026HCGWADA. 2026 World Anti-Doping Code Prohibited List. Section S2 — Peptide hormones, growth factors, related substances, and mimetics. World Anti-Doping Agency. (hCG specifically prohibited in males.)regulatory / registry
2000HCGU.S. Food and Drug Administration. Ovidrel (choriogonadotropin alfa) Prescribing Information. EMD Serono. First approved 2000.regulatory / registry
HCGU.S. Food and Drug Administration. Pregnyl (chorionic gonadotropin) Prescribing Information. Organon USA Inc.regulatory / registry
HCGU.S. Food and Drug Administration. Novarel (chorionic gonadotropin) Prescribing Information. Ferring Pharmaceuticals.regulatory / registry
2018HCGLee JA, Ramasamy R. Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men. Transl Androl Urol. 2018;7(Suppl 3):S348-S352. PMID: 30050800. PMID 30050800research article
2017HCGShiraishi K, Matsuyama H. Gonadotoropin actions on spermatogenesis and hormonal therapies for spermatogenic disorders. Endocr J. 2017;64(2):123-131. PMID: 28100858. PMID 28100858research article
2015HCGRamasamy R, Armstrong JM, Lipshultz LI. Preserving fertility in the hypogonadal patient: an update. Asian J Androl. 2015;17(2):197-200. PMID: 25652635. PMID 25652635research article
2013HCGCrosnoe LE, Grober E, Ohl D, Kim ED. Exogenous testosterone: a preventable cause of male infertility. Transl Androl Urol. 2013;2(2):106-113. PMID: 26813847. (Mechanism and clinical framing of TRT-induced infertility and hCG-based prevention.) PMID 26813847research article
2003InsulinRiddle MC, Rosenstock J, Gerich J; Insulin Glargine 4002 Study Investigators. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003;26(11):3080-3086. PMID: 14578243. PMID 14578243human trial
1998InsulinUK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-853. PMID: 9742976. PMID 9742976human study
1997InsulinAnderson JH Jr, Brunelle RL, Koivisto VA, et al. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group. Diabetes. 1997;46(2):265-270. PMID: 9000704. PMID 9000704human study
1993InsulinThe Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986. PMID: 8366922. PMID 8366922human study
InsulinBanting FG, investigated CH. The internal secretion of the pancreas. J Lab Clin Med. 1922;7(5):251-266. (Foundational discovery of insulin.)mechanism / discovery
2026InsulinWorld Anti-Doping Agency. 2026 Prohibited List — Section S4: Hormone and Metabolic Modulators. wada-ama.org.regulatory / registry
InsulinU.S. Food and Drug Administration. Humulin, Humalog, Novolog, Lantus, Toujeo, Levemir, Tresiba prescribing information. FDA.gov.regulatory / registry
2020InsulinGarber AJ, Handelsman Y, Grunberger G, et al. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm — 2020 executive summary. Endocr Pract. 2020;26(1):107-139.… PMID 32022600research article
2017InsulinMarso SP, McGuire DK, Zinman B, et al; DEVOTE Study Group. Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes. N Engl J Med. 2017;377(8):723-732. PMID: 28605603. PMID 28605603research article
2012InsulinGerstein HC, Bosch J, Dagenais GR, et al; ORIGIN Trial Investigators. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med. 2012;367(4):319-328. PMID: 22686416. PMID 22686416research article
2009InsulinDandona P, Chaudhuri A, Ghanim H, Mohanty P. Insulin as an anti-inflammatory and antiatherogenic modulator. J Am Coll Cardiol. 2009;53(5 Suppl):S14-S20. PMID: 19179212. PMID 19179212research article
2008InsulinHolman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577-1589. PMID: 18784090. (UKPDS legacy follow-up.) PMID 18784090research article

Related pair pages

More research context

Frequently asked

Have HCG and Insulin been studied together?

No co-administration studies between HCG and Insulin are catalogued on Kalios. The pair page lists only the individual published literature for each compound and any shared mechanism tags.

What mechanisms do HCG and Insulin share?

HCG and Insulin share these mechanism tags on their Kalios profiles: hormone. Tags are descriptive and verbatim from each compound profile — not an inference of combined effect.

What is the FDA status of HCG and Insulin?

HCG: Approved (hypogonadism, cryptorchidism, infertility). Insulin: Approved (1923 animal; 1982 rDNA). FDA-status text is pulled verbatim from each compound profile. See /fda-pcac-2026.html for the broader FDA Pharmacy Compounding Advisory Committee context.

Where can I find the full research on HCG and Insulin?

Full citation lists, dosing tables from the literature, reconstitution data, and the FDA / WADA status are on the individual compound profiles: the HCG profile and the Insulin profile. The Kalios Stack Research Tool hub lists every compound covered.

Last updated: April 2026